Share Issue Gives Cellectricon SEK 89 Million to Continue its Rapid Market Expansion

    GOTHENBURG, Sweden, Feb. 21 /CNW/ - With two successful international
product launches, Swedish biotech firm Cellectricon is entering a new
expansion phase. The share issue will strengthen Cellectricon's financial
capacity prior to a number of significant product launches in 2008-2009. These
products have been developed in close collaboration with leading global
pharmaceutical companies to meet the industry's increasing demand for fully
automated, highly efficient systems for pre-clinical pharmaceutical
    "Cellectricon is now entering a new expansion phase, in which the company
will soon launch two large-scale systems that will revolutionize drug
discovery. This capital will enable us to continue our rapid expansion in the
United States, Europe, and Asia," said Dr. Mattias Karlsson, Cellectricon's
    In 2008 Cellectricon will launch the first of their large-scale screening
system, Cellaxess(R)HT, which has been developed in close cooperation with one
of the world's largest pharmaceutical companies. Cellaxess(R)HT will be the
only system on the market that enables large-scale supply of genetic material
for cells and is tailor made for high throughput RNAi screening.

    About Cellectricon

    Cellectricon AB is a Swedish biotech company that is a successful
provider of groundbreaking products to the pharmaceutical industry that
increase efficiency in pre-clinical pharmaceutical development. Cellectricon
has already successfully launched two products onto the market that have been
sold to ten of the 12 largest pharmaceutical companies in the world. In 2007
the company increased its revenue by almost 50%. In 2008-2009 launch the
high-performance systems Cellaxess(R)HT for RNAi screening and Dynaflow(R)HT
for ion channel screening. Cellectricon's forthcoming products address a
market that is estimated to be US $1.4 billion by 2010.

For further information:

For further information: Susanne Fagerlund, VP Market Communications,
Telephone: +46(0)31-760-35-15, E-mail:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890